CDC anthrax vaccine safety & efficacy research program (Record no. 92009)

MARC details
000 -LEADER
fixed length control field 01441nam a2200337Ia 4500
001 - CONTROL NUMBER
control field ebr10071921
003 - CONTROL NUMBER IDENTIFIER
control field CaPaEBR
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260707175100.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m u
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 020131s2001 dcuad sb 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency CaPaEBR
Transcribing agency CaPaEBR
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)646728082
050 14 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RA644.A6
Item number C4 2001eb
090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (OCLC)
-- 92009
-- 71886
245 00 - TITLE STATEMENT
Title CDC anthrax vaccine safety & efficacy research program
Medium [electronic resource] :
Remainder of title interim report /
Statement of responsibility, etc Institute of Medicine.
246 30 - VARYING FORM OF TITLE
Title proper/short title CDC anthrax vaccine safety and efficacy research program
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Washington, D.C. :
Name of publisher, distributor, etc National Academy Press,
Date of publication, distribution, etc c2001.
300 ## - PHYSICAL DESCRIPTION
Extent xii, 45 p. :
Other physical details ill.
500 ## - GENERAL NOTE
General note "Prepublication copy; uncorrected proofs".
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references.
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction.
Place of reproduction Palo Alto, Calif. :
Agency responsible for reproduction ebrary,
Date of reproduction 2009.
Note about reproduction Available via World Wide Web.
-- Access may be limited to ebrary affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Anthrax
General subdivision Vaccination.
9 (RLIN) 101698
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Vaccines
General subdivision Effectiveness.
9 (RLIN) 117448
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Vaccines
General subdivision Safety measures.
9 (RLIN) 117449
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
Source of term local
9 (RLIN) 190
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Institute of Medicine (U.S.)
9 (RLIN) 103418
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Communicable Disease Center (U.S.)
9 (RLIN) 117450
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element ebrary, Inc.
9 (RLIN) 191
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://site.ebrary.com/lib/strathmore/Doc?id=10071921">http://site.ebrary.com/lib/strathmore/Doc?id=10071921</a>
Public note An electronic book accessible through the World Wide Web; click to view

No items available.


© Strathmore University Library
Madaraka Estate, Ole Sangale Road | P. O. Box 59857 - 00200 City Square, Nairobi, Kenya
(+254) (0)703 034 000/200/300 | (+254) (0)20-607498